<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Panya A</submitter><funding>undefined  &amp;lt;span style=&amp;quot;color:gray;font-size:10px;&amp;quot;&amp;gt;undefined&amp;lt;/span&amp;gt;</funding><pagination>E1267</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7694746</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(11)</volume><pubmed_abstract>Dengue virus (DENV) infection has become a critically important globally prevalent infectious disease, especially in tropical and subtropical countries. Since neither currently exists, there is an urgent need for an effective vaccine to prevent, and a specific drug to treat DENV infection. Therapeutic peptides represent an attractive alternative for development into anti-DENV drugs due to their safety and their diverse biological and chemical properties. We recently reported novel bioactive peptides extracted from the Asian medicinal plant &lt;i>Acacia catechu&lt;/i> that efficiently inhibited all four DENV serotypes. In this study, we investigated the anti-DENV activity of a synthetic bioactive peptide derived from this plant. The most effective peptide (designated Pep-RTYM) inhibited DENV infe</pubmed_abstract><journal>Viruses</journal><pubmed_title>A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant &lt;i>Acacia catechu&lt;/i> Binds to Dengue Virus and Inhibits Cell Entry.</pubmed_title><pmcid>PMC7694746</pmcid><funding_grant_id>xx</funding_grant_id><pubmed_authors>Choowongkomon K</pubmed_authors><pubmed_authors>Sawasdee N</pubmed_authors><pubmed_authors>Rotarayanont S</pubmed_authors><pubmed_authors>Panya A</pubmed_authors><pubmed_authors>Yenchitsomanus PT</pubmed_authors><pubmed_authors>Songprakhon P</pubmed_authors><pubmed_authors>Tragoolpua Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant &lt;i>Acacia catechu&lt;/i> Binds to Dengue Virus and Inhibits Cell Entry.</name><description>Dengue virus (DENV) infection has become a critically important globally prevalent infectious disease, especially in tropical and subtropical countries. Since neither currently exists, there is an urgent need for an effective vaccine to prevent, and a specific drug to treat DENV infection. Therapeutic peptides represent an attractive alternative for development into anti-DENV drugs due to their safety and their diverse biological and chemical properties. We recently reported novel bioactive peptides extracted from the Asian medicinal plant &lt;i>Acacia catechu&lt;/i> that efficiently inhibited all four DENV serotypes. In this study, we investigated the anti-DENV activity of a synthetic bioactive peptide derived from this plant. The most effective peptide (designated Pep-RTYM) inhibited DENV infe</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2026-05-04T04:17:43.368Z</modification><creation>2021-02-20T00:55:47Z</creation></dates><accession>S-EPMC7694746</accession><cross_references><pubmed>33172110</pubmed><doi>10.3390/v12111267</doi></cross_references></HashMap>